HapMap-based Study: CYP2A13 May Be a Potential Key Metabolic Enzyme Gene in the Carcinogenesis of Lung Cancer in Non-Smokers

Thoracic Cancer - Australia
doi 10.1111/1759-7714.12954
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

A Gene-Based Risk Score for Lung Cancer Susceptibility in Smokers and Ex-Smokers

Postgraduate Medical Journal
Medicine
2009English

Overexpression of HCC1/CAPERα May Play a Role in Lung Cancer Carcinogenesis

Tumor Biology
MedicineCancer Research
2014English

Metabolic Gene NR4A1 as a Potential Therapeutic Target for Non-Smoking Female Non-Small Cell Lung Cancer Patients

Thoracic Cancer
MedicinePulmonaryRespiratory MedicineOncology
2019English

Characterization of CYP2A13*2, a Variant Cytochrome P450 Allele Previously Found to Be Associated With Decreased Incidences of Lung Adenocarcinoma in Smokers

Drug Metabolism and Disposition
PharmacologyPharmaceutical Science
2008English

The EMSY Gene Collaborates With CCND1 in Non-Small Cell Lung Carcinogenesis

International Journal of Medical Sciences
Medicine
2017English

A Hospital Based Study on Lipid Profile in Smokers and Non Smokers- A Comparative Study

Journal of Evolution of Medical and Dental Sciences
2012English

P2.10-15 RADON: #1 Cause of Lung Cancer in Non-Smokers

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Should Never-Smokers at Increased Risk for Lung Cancer Be Screened?

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2015English

Whole Blood microRNA Expression May Not Be Useful for Screening Non-Small Cell Lung Cancer

PLoS ONE
Multidisciplinary
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy